Live Biologics & The Microbiome With 4D pharma's Duncan Peyton
Business Of Biotech · 51 minutes ·

Live Biologics & The Microbiome With 4D pharma's Duncan Peyton

4D pharma's flagship early-stage clinical candidates are live biotherapeutics, a relatively new class of biologics that seek to impact disease state by modulating the microbiome. CEO Duncan Peyton is leading the effort to understand how the health of the microbiome relates to a wide range of diseases, including immuno-oncology, central nervous system disorders, respiratory disease, auto immune indications, and gastro intestinal disease. 4D pharma is even working on a live biotherapeutic vaccine platform. Join Duncan on this episode of the Business of Biotech as we discuss this new frontier of therapeutic exploration.

Learn more about gut microbiome therapeutic up-and-comers at bioprocessonline.com

Comments (0)

You Must Be Logged In To Comment

Similar podcasts

The Intestinal Microbiome and the Developing Immune System

Life Sciences Connect

Explore Life Sciences

Management Information Science

Practice Management Live

Live Life With Ease

Living 4D with Paul Chek